Open Beta
TREN
MetriLume
TREN

US marketsLENZ

SEC-sourced researchBeta

LENZ

LENZ Therapeutics, Inc.

Company comparison ↗

Data passport

CIK
0001815776
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Sep 8, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 0.0000 USD; December 2025: 19,088,000.0000 USD19.1M USD0 USD0December 2024December 2025
LENZ · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20240.0000Mar 24, 2026
December 202519,088,000.0000Mar 24, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202519,088,000.0000-82,127,000.0000-69,170,000.0000305,876,000.000021,537,000.0000Mar 24, 2026
December 20240.0000-49,769,000.0000-59,391,000.0000215,304,000.000011,220,000.0000Mar 24, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$19.09MDecember 2025Mar 24, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$0December 2024Mar 24, 202610-K
Net incomeNetIncomeLoss-$82.13MDecember 2025Mar 24, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$69.17MDecember 2025Mar 24, 202610-K
Total assetsAssets$305.88MDecember 2025Mar 24, 202610-K
Total liabilitiesLiabilities$21.54MDecember 2025Mar 24, 202610-K

New filings

Explore methodology ↗